- Home
- IPHA vs APPS Comparison
IPHA vs APPS Comparison
Compare IPHA & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- APPS
- Stock Information
- Founded
- IPHA 1999
- APPS 2007
- Country
- IPHA France
- APPS United States
- Employees
- IPHA N/A
- APPS N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- APPS Multi-Sector Companies
- Sector
- IPHA Health Care
- APPS Miscellaneous
- Exchange
- IPHA Nasdaq
- APPS Nasdaq
- Market Cap
- IPHA 178.0M
- APPS 153.5M
- IPO Year
- IPHA 2019
- APPS N/A
- Fundamental
- Price
- IPHA $2.07
- APPS $1.75
- Analyst Decision
- IPHA Strong Buy
- APPS Hold
- Analyst Count
- IPHA 1
- APPS 4
- Target Price
- IPHA $11.50
- APPS $2.38
- AVG Volume (30 Days)
- IPHA 1.5M
- APPS 3.0M
- Earning Date
- IPHA 09-12-2024
- APPS 02-05-2025
- Dividend Yield
- IPHA N/A
- APPS N/A
- EPS Growth
- IPHA N/A
- APPS N/A
- EPS
- IPHA N/A
- APPS N/A
- Revenue
- IPHA $36,202,722.00
- APPS $491,574,000.00
- Revenue This Year
- IPHA N/A
- APPS N/A
- Revenue Next Year
- IPHA $102.87
- APPS $9.20
- P/E Ratio
- IPHA N/A
- APPS N/A
- Revenue Growth
- IPHA N/A
- APPS N/A
- 52 Week Low
- IPHA $1.29
- APPS $1.18
- 52 Week High
- IPHA $3.51
- APPS $7.30
- Technical
- Relative Strength Index (RSI)
- IPHA 53.12
- APPS 50.08
- Support Level
- IPHA $1.47
- APPS $1.40
- Resistance Level
- IPHA $2.36
- APPS $1.78
- Average True Range (ATR)
- IPHA 0.32
- APPS 0.12
- MACD
- IPHA 0.06
- APPS 0.08
- Stochastic Oscillator
- IPHA 29.99
- APPS 69.16
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.